Abstract
BackgroundClinical remission or low disease activity (LDA) are now realistic targets in the management of patients with rheumatoid arthritis (RA), especially in early disease and thanks to biologic treatments. The...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
